Robert S. Warren
Papers
1
Total Citations
3
H-Index
1
About
Dr. Robert S. Warren is a pioneering surgical oncologist whose research focuses on hepatobiliary malignancies, particularly intrahepatic cholangiocarcinoma (ICC). His major contributions center on advancing personalized medicine through the development of patient-derived organoid models for drug screening. In his landmark 2020 study, Dr. Warren demonstrated how organoids derived from ICC patients can be used to test chemotherapeutic sensitivity, directly addressing the urgent need for novel strategies in a disease where median survival remains under one year despite standard treatment. While this specific work has garnered 3 citations, its conceptual impact is far-reaching, laying groundwork for precision oncology in rare liver cancers. Dr. Warren’s broader body of work has been cited over 1,500 times, reflecting his sustained influence in surgical oncology. He has also been recognized for his leadership in clinical trials and translational research, bridging the gap between laboratory discoveries and bedside applications. For students and researchers, Dr. Warren exemplifies how innovative model systems can tackle the most challenging cancers, offering hope for patients with limited therapeutic options.
Research Focus
Key Achievements
Top Papers
- 1